Silke Peter
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 33
-
- Genomics and Phylogenetic Studies 11
- Gut microbiota and health 9
- Co-authors
- Matthias Willmann (30 shared papers)Ingo B. Autenrieth (22 shared papers)Matthias Marschal (15 shared papers)Philipp Oberhettinger (12 shared papers)Jan Liese (12 shared papers)Wichard Vogel (12 shared papers)Michael Buhl (4 shared papers)Daniela Dörfel (7 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)Journal of Clinical Microbiology (5 papers)Journal of Antimicrobial Chemotherapy (5 papers)Frontiers in Microbiology (4 papers)BMC Infectious Diseases (3 papers)
- Partner nations
- GermanyNetherlandsSwitzerland
In The Last Decade
Silke Peter
71 papers receiving 3.7k citations
Silke Peter's Hit Papers
Peers
Comparison fields: 5 of 138
- Molecular Medicine 691
- Applied Microbiology and Biotechnology 151
- Clinical Biochemistry 377
- Infectious Diseases 898
- Rheumatology 541
Countries citing papers authored by Silke Peter
This map shows the geographic impact of Silke Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Peter more than expected).
Fields of papers citing papers by Silke Peter
This network shows the impact of papers produced by Silke Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Peter. The network helps show where Silke Peter may publish in the future.
Co-authors
The 25 scholars most cited alongside Silke Peter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Matrix Metalloproteinases: Role In Arthritis Hit paper breakdown → | 2006 | 1102 |
| 2 | Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment Hit paper breakdown → | 2020 | 802 |
| 3 | 2017 | 137 | |
| 4 | 2011 | 126 | |
| 5 | 2013 | 117 | |
| 6 | 2019 | 112 | |
| 7 | 2015 | 77 | |
| 8 | 2014 | 74 | |
| 9 | 2020 | 66 | |
| 10 | 2017 | 65 | |
| 11 | 2019 | 61 | |
| 12 | 2018 | 56 | |
| 13 | 2015 | 52 | |
| 14 | 2018 | 51 | |
| 15 | 2017 | 51 | |
| 16 | 2015 | 49 | |
| 17 | 2021 | 38 | |
| 18 | 2019 | 34 | |
| 19 | 2014 | 32 | |
| 20 | 2021 | 29 |
About Silke Peter
Silke Peter is a scholar working on Molecular Medicine, Molecular Biology, Infectious Diseases, Clinical Biochemistry and Endocrinology, having authored 74 papers that have together received 3.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (33 papers), Genomics and Phylogenetic Studies (11 papers), Bacterial Identification and Susceptibility Testing (10 papers), Gut microbiota and health (9 papers), Antibiotic Use and Resistance (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Pharmaceutical and Antibiotic Environmental Impacts (5 papers) and Vibrio bacteria research studies (4 papers). The work is most often cited by research in Molecular Medicine (691 citations), Applied Microbiology and Biotechnology (151 citations), Clinical Biochemistry (377 citations), Infectious Diseases (898 citations) and Rheumatology (541 citations). Silke Peter has collaborated with scholars based in Germany, Netherlands and Switzerland. Frequent co-authors include Matthias Willmann, Ingo B. Autenrieth, Matthias Marschal, Philipp Oberhettinger, Jan Liese, Wichard Vogel, Michael Buhl, Daniela Dörfel, Stephan Ossowski and Erik C. Böttger. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Frontiers in Microbiology and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.